Consolidated Statements of Cash Flows (Unaudited) - USD ($)		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income		$ 19,813,000	$ 17,887,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		26,242,000	24,538,000
Amortization of deferred loan costs		823,000	820,000
Gain on sale of properties		(10,212,000)	(9,626,000)
Loss on disposal of assets		183,000	500,000
Bad debt		1,031,000	946,000
Share-based compensation		2,805,000	2,485,000
Deficit in earnings of real estate partnership		28,000	1,627,000
Amortization of right-of-use assets - finance leases		65,000	72,000
Changes in operating assets and liabilities:
Escrows and deposits		6,238,000	2,282,000
Accrued rents and accounts receivable		(2,980,000)	(4,359,000)
Receivable due from related party		(40,000)	(128,000)
Unamortized lease commissions, legal fees and loan costs		(1,992,000)	(2,644,000)
Prepaid expenses and other assets		1,705,000	2,432,000
Accounts payable and accrued expenses		(4,114,000)	(1,011,000)
Payable due to related party		0	16,000
Tenants' security deposits		561,000	17,000
Net cash provided by operating activities		40,156,000	35,854,000
Cash flows from investing activities:
Acquisitions of real estate		(50,137,000)	(25,474,000)
Additions to real estate		(15,485,000)	(12,748,000)
Proceeds from sales of properties		46,444,000	13,447,000
Net cash used in investing activities		(19,178,000)	(24,775,000)
Cash flows from financing activities:
Distributions paid to common shareholders		(18,325,000)	(17,754,000)
Distributions paid to OP unit holders		(240,000)	(249,000)
Proceeds from issuance of common shares, net of offering costs		7,620,000	0
Payments of exchange offer costs		(81,000)	0
Net (payments of) proceeds from credit facility		(17,000,000)	34,000,000
Repayments of notes payable		(47,950,000)	(29,823,000)
Proceeds from notes payable		56,340,000	0
Payments of loan origination costs		(789,000)	0
Repurchase of common shares		(2,641,000)	(525,000)
Payment of finance lease liability		(18,000)	(10,000)
Net cash used in financing activities		(23,084,000)	(14,361,000)
Net decrease in cash, cash equivalents and restricted cash		(2,106,000)	(3,282,000)
Cash, cash equivalents and restricted cash at beginning of period		4,640,000	6,355,000
Cash, cash equivalents and restricted cash at end of period (1)	[1]	2,534,000	3,073,000
Supplemental disclosure of cash flow information:
Cash paid for interest		25,384,000	23,223,000
Cash paid for taxes		432,000	435,000
Non cash investing and financing activities:
Disposal of fully depreciated real estate		29,000	864,000
Financed insurance premiums		2,638,000	3,002,000
Value of shares issued under dividend reinvestment plan		56,000	55,000
Change in fair value of cash flow hedge		(3,296,000)	6,602,000
Accrued capital expenditures		1,439,000	0
Receivable from partnership redemption		31,643,000	0
Recognition of finance lease liability		86,000	0
Cash, cash equivalents and restricted cash
Cash and cash equivalents		2,534,000	2,976,000
Restricted cash		0	97,000
Total cash, cash equivalents and restricted cash		2,534,000	3,073,000
Conversion of OP Units to Common Stock [Member]
Non cash investing and financing activities:
Value of common shares exchanged for OP units		$ 355,000	$ 16,000

[1] For a reconciliation of cash, cash equivalents and restricted cash, see supplemental disclosures below.